Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery
ConclusionPAI is a highly promising methodology for increasing detection of tumors in fluorescence-guided surgery. Although not yet clinically approved, IRDye 680LT demonstrates promise as an untargeted agent when paired with ABY-029. The clinical translation of PAI to maximize tumor excision, while minimizing normal tissue removal, could improve both patient survival and life quality.
Source: Molecular Imaging and Biology - Category: Molecular Biology Source Type: research
More News: Biology | Cancer & Oncology | Carcinoma | Molecular Biology | Oral Cancer | PET Scan | Squamous Cell Carcinoma | Study